chimeras are specifically tolerant to the tissues of the host. Thus, lack of GVHD is not dependent upon the continued presence of suppressor cells of host (BALB/c) origin or on chronic immunodeficiency of the donor-type cells.
Materials and Methods
Chimeras. BALB/c (H-2 a) mice, 4-6-mo old, were given TLI in 17 fractions of 200 rad each as described previously (1) . 1 d later, BM cells (30 × 10 n) from C57BL/Ka (H-2 b) donors were infused via the lateral tail vein. Chimerism of the PBL of individual BM recipients was assayed at least 40 d after transplantation by a complement (C')-dependent microcytotoxicity assay using BALB/c anti-C57BL/Ka antiserum (1) .
Adoptive Transfer Recipients. Adult (3-to 6-too old) male and female BALB/c and C3H (H-2 k) mice were used as whole-body irradiated (WBI) recipients of chimeric and normal spleen cells in GVHD mortality experiments. WBI was delivered using a 250-kV, 15-mA Philips unit (Philips Electronic Instruments, Inc., Mahwah, N. J.) at a dose rate of 93 rad/min. Neomycin sulfate (500 #g/ml) and polymyxin B (100 #g/ml) were added to drinking water before WBI and continued indefinitely.
Isolation of Chimeric Spleen Cells of Donor (C57BL/Ka)
Origin. Four to six C57BL/Ka BALB/c chimeras (>100 d after transplantation) were used for each experiment. Single-cell suspensions were prepared in cold RPMI-1640 medium (Grand Island Biological Co., Grand Island, N. Y.). The cells were spun at 250 g and resuspended at 10 X 10S/ml in RPMI-1640 medium that contained 0.3% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.). C57BL/Ka anti-BALB/c alloantiserum was added to a final concentration of 1:50 for 30 min at 37°C. After spinning at 250 g for 10 rain at room temperature, the unbound antiserum was removed. The cells were resuspended (20 X 10e/ml) in rabbit C' (1:8) (Lo-Tox; Cedarlane Medical Laboratories Ltd., Ontario, Canada) at 37°C for 45 min and then spun for 10 min at 250 g. The cells were washed two times in fresh medium, counted, and adjusted to the appropriate concentration in RPMI-1640. In preliminary experiments with antiserum concentrations of 1:100 or greater, this procedure resulted in 90-100% cytotoxicity for BALB/c spleen cells and <5% cytotoxicity for normal C57BL/Ka spleen cells. To assess the specificity of graft vs. host tolerance in the C57BL/Ka --* BALB/c chimeras, third-party mice of the C3H strain (H-2 k) were treated with sublethal WBI (650 rad) and given 25 × 106 chimeric spleen cells intravenously. G3H recipients were treated with a higher radiation dose to achieve a similar radiation mortality to that observed with BALB/c mice given 500-550 rad WBI (Table I) . None of five survived >30 d after cell transfer. 38 of 44 mice given radiation alone survived >45 d, but none of 26 given WBI and normal G57BL/Ka spleen cells survived >15 d. These experiments suggested, but did not prove, that the donor-type cells in chimeric spleen were both immunocompetent and specifically tolerant to host tissues. The possibility remained that the GVHD observed in third-party mice was mediated by cells of host origin (~20% of the chimeric spleen cells), and that lack of GVHD in BALB/c recipients was mediated by suppressor cells of host origin. These alternative explanations pointed to the need to assess the graft vs. host reactivity of an isolated population of chimeric donor-types cells.
Results and Discussion
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Specific Absence of GVHD Potential of Donor-Type (H-2 b) Chimera Spleen Cells. We isolated donor-type (C57BL/Ka) spleen cells from C57BL/Ka ~ BALB/e chimeras >100 d after BM transplantation. Pooled spleen cells (~80% C57BL/Ka) were treated in vitro with C57BL/Ka anti-BALB/c alloantiserum (anti-BALB/c) and rabbit C' to eliminate cells of host (BALB/c) origin. The remaining cells were washed, and aliquots that contained 25 × 106 viable cells were injected intravenously into sublethally irradiated BALB/c and third-party (C3H) hosts (Table II) . Data in Table II (Table II) . The syngeneic inoculum presumably leads to rejection of the allogeneic cells because chimerism was not produced. However, treatment of the spleen cell mixture with anti-BALB/c antiserum and C' eliminated the protective effect, because none of 12 survived > 15 d. This result provided further evidence that the cytotoxicity method used in these studies eliminated host-type (BALB/c) cells, but allowed donor-type cells to mediate GVHD.
Development of Chimerism in Irradiated BALB/c Recipients Given Donor-Type (H-2 b)
Chimeric or FI Hybrid Spleen Cells. 9 of 20 irradiated BALB/c mice (500-550 rad) given donor-type cells (25 × 106) from long-term TLI chimeras developed stable mixed chimerism (Table II) . The PBL of the adoptive recipients contained a mean of 44% donor-type cells when tested at least 40 d after cell transfer. The infusion of untreated chimeric spleen cells led to stable chimerism in only 2 of 9 BALB/c recipients given 500-550 rad WBI and in none of the recipients given 450 rad (Table I ). The data suggest that rejection of allogeneic cells by the lightly irradiated hosts may account for the failure to achieve uniform chimerism. The more effective transfer ofchimerism with isolated chimeric donor-type cells suggests the possibility that host-type cells have a proliferative advantage in recipients of unfractionated spleen cells.
The transfer of tolerance with chimeric donor spleen cells could have been mediated by suppressor cells of donor origin, or alternatively, by donor antigens acting as tolerogens. The latter mechanism is more likely, because the majority of BALB/e mice given 500-550 rad WBI and (BALB/c × C57BL/Ka)F1 spleen or BM cells (60 × 106) developed high levels of stable chimerism (Table III) , and accepted C57BL/Ka but not C3H skin grafts indefinitely (M. Gottlieb, S. Strober, and H. S. Kaplan. Unpublished observations.). It would appear that in this strain combination, the injection of cell populations that cannot mediate a graft vs. host reaction (i.e., Fa or donor-type chimeric spleen cells) produces stable mixed chimerism and tolerance in recipients given sublethal WBI.
The literature contains several examples of stable allogeneic BM chimeras in adult mice and rats prepared with lethal WBI or cyclophosphamide. These chimeras have been constructed in F1 hybrids by infusion of parental BM cells treated with antiThy-1 antiserum and C', or in completely allogeneic combinations by selection of donor-recipient strains where a substantial proportion of recipients survive GVHD (8) (9) (10) (11) . Lymphocytes from lethally irradiated F1 hybrid recipients of treated BM from one parent proliferate in response to cells of the other parent in vitro (MLR), but do not produce specific cell-mediated lympholysis (CML) (8) . Suppressor cells of the CML could not be demonstrated, suggesting that the clone of cytotoxic lymphocytes responsive to the host tissues had been deleted. However, studies in fully allogeneic r.at chimeras that survive transient GVHD suggest that suppressor cells maintain the tolerant state (11) . Multiple mechanisms may be operative in these instances of graft vs. host tolerance as seems to be the case for neonatal tolerance (12) . Our experiments in progress attempt to determine whether graft vs. host tolerance in TLI chimeras is mediated by antigen-specific suppressor T cells of donor origin or by deletion of specific host-reactive lymphocyte clones. An ongoing role for serum blocking factors in chimeras is less likely because washed donor-type spleen cells in the absence of chimeric serum led to sustained chimerism without GVHD in BALB/c mice given sublethal WBI. Summary BALB/c mice given allogeneic (C57BL/Ka) bone marrow cells after total lymphoid irradiation become stable chimeras with ~80% donor-type and 20% host-type cells in the spleen. The chimeras do not develop graft vs. host disease (GVHD). Purified cells of C57BL/Ka origin from the chimeras mediated GVHD in lightly irradiated C3H (third party), but not in BALB/c (host-strain) mice. Thus graft vs. host tolerance in the chimeras could not be explained by complete immunodeficiency of donor-type cells, serum blocking factors, or suppressor cells of host (BALB/c) origin. Clonal deletion or suppression of lymphocytes reactive with host tissues remain possible explanations. The transfer of donor-type chimeric spleen cells to BALB/c recipients given 500-550 rad whole-body irradiation WBI led to stable mixed chimerism in ~50% of recipients. The cells were presumably acting as tolerogens because similarly irradiated BALB/c mice given (BALB/c × C57BL/Ka)F1 spleen or bone marrow cells also became stable mixed chimeras.
